Loading…
An open-label, randomized phase I treatment trial (Parallel Assignment) to evaluate the impact of PRIM-DJ2727 (frozen vs capsules) in patients with active Ulcerative Colitis (UC) defined on clinical grounds (Partial Mayo score ≥ 3 with each subscore >1).
Disease severity as assessed by the Partial Mayo Score (PMS) for Ulcerative Colitis (UC), Change in fecal microbiota diversity and genera as assessed by sequencing, Change in proportion of antibody-coated microbiota as assessed by the antibiotic susceptibility test, Safety
No published results were found as of May 2026